Skip to main content
. Author manuscript; available in PMC: 2022 Apr 4.
Published in final edited form as: Neurol Clin. 2020 Sep 12;38(4):913–936. doi: 10.1016/j.ncl.2020.07.008

Table 1.

Biomarkers of manganese exposure

Acute Exposures
Cumulative Exposures
Blood Urine Saliva Hair Nails Bone

Most widely used biomarker of Mn exposure38 Poor correlation between Mn exposure and Mn levels in urine39 Although levels are present at concentrations similar to blood, saliva is an alternative noninvasive biomarker for Mn exposure39 Quantifies longer-term cumulative exposures transpiring over several months40 Fingernails and toenails are noninvasive measures that represent aggregate exposures spanning from several months to approximately 1 y37 Approximately 40% of Mn is stored in bone45

Mn in blood has a short half-life of hours10 Past studies have not made significant observations using urine as a Mn biomarker38 Saliva Mn levels seem to linearly increase with exposure39 Exogenous contamination is a significant concern40 Mn concentrations quantified in nails have been associated with levels of Mn in the striatum and midbrain regions41,42 of the brain Estimated half-life of Mn in bone is 8 y10
Optimal for acute exposures37 such as occupational settings The future use of urine as a marker of Mn exposure is not recommended30 Use of saliva as a Mn biomarker is questionable10,38,39 Used as a noninvasive biomarker in many studies40 Bone Mn concentrations have been correlated with Mn levels in the brain, specifically the striatum, hippocampus, and choroid plexus43